Hypercholesterolemia as one of the risk factors of intracerebral hemorrhage

Acta Neurologica Belgica

Volumn 113, Issue 4, 2013, Pages 459-462

  Bozluolcay, Melda ^a   Nalbantoglu, Mecbure ^a   Gozubatik Celik, R Gokcen ^a   Benbir, Gulcin ^a   Akalin, Mehmet Ali ^a   Erkol, Gokhan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hypercholesterolemia; Intracerebral hemorrhage; Risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BASAL GANGLION; BRAIN DAMAGE; BRAIN HEMORRHAGE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEMISPHERE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SMOKING; SUBARACHNOID SPACE; THALAMUS;

CEREBRAL HEMORRHAGE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84891641105     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-013-0222-6     Document Type: Article

References (19)

1. Carhuopama JR, Mayer SA, Hanley DF (2010) Intracerebral Hemorrhage. The epidemiology of intracerebral hemorrhage. Cambridge University Press, Cambridge, pp 1-15.
2. Kase CS, Mohr JP, Caplan LR (2004) Stroke: pathophysiology, diagnosis, and management risk. Intracerebral Hemorrhage 13: 327-376.
3. Bejot Y, Osseby GV, Gremeaux V, Durier J, Rouaud O, Moreau T, Giroud M (2009) Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study. J Neurol Sci 287: 84-88.
4. Siracuse JJ, Robich MP, Gautam S, Kasper EM, Moorman DW, Hauser CJ (2010) Antiplatelet agents, warfarin, and epidemic intracranial hemorrhage. Surgery 148: 724-730.
5. Nago N, Ishikawa S, Goto T, Kayaba K (2011) Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School cohort study. J Epidemiol 21: 67-74.
6. Suzuki K, Izumi M, Sakamato T, Hayashi M (2011) Blood pressure and total cholesterol level are critical risks especially for hemorrhagic stroke in Akita, Japan. Cerebrovasc Dis 31: 100-106.
7. Tirschwell DL, Smith NL, Heckbert SR, Lemaitre RN, Longstreth WT Jr, Psaty BM (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63: 1868-1875.
8. Tveiten A, Ljostad U, Mygland A, Thomassen L, Pripp AH, Naes H (2012) Intracerebral hemorrhage in Southern Norway-a hospital-based incidence study. Eur Neurol 67: 240-245.
9. Kim YZ, Park YH, Song YG, Kim KH (2012) Clinical analysis of factors predisposing the recurrence of primary intracerebral hemorrhage in patients taking anti-hypertensive drugs: a prospective cohort study. Clin Neurol Neurosurg 3033: 1-9.
10. Soo YOY, Siu DYW, Abrigo J, Yu S, Ng N, Ahuja AT, Wong LKS, Leung TW (2012) Risk of intracerebral hemorrhage in patients with cerebral microbleeds undergoing endovascular intervention. Stroke 43: 1532-1536.
11. Hankey GJ, Wong KSL, Chankrachang S, Chen C, Crimmins D, Frayne J, Kim JS, Li Y, Liou CW, Merican JS, Misbach J, Navarro J, Shinohara Y, Wang Y, Yoon BW (2010) Management of cholesterol to reduce the burden of stroke in Asia: consensus statement. Int J Stroke 5: 209-216.
12. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G (2012) Total and high-density lipoprotein cholesterol and stroke risk. Stroke 43: 1768-1774.
13. Ikram MA, Wieberdink RG, Koudstaal PJ (2012) International epidemiology of intracerebral hemorrhage. Curr Atheroscler Rep 14: 300-306.
14. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, Mac Leod MJ, Sillesen H, Zweifler R, Michael K, Welch A, Behalf of SPARCL Investigators (2009) Statin treatment and stroke outcome in the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Stroke 40: 3526-3531.
15. LaRosa JC, Pedersen TR, Somaratne R, Wasserman SM (2013) Safety and effect of very low levels of low density lipoprotein cholesterol on cardiovascular events. Am J Cardiol 111: 1221-1229.
16. Collins R, Armitage J, Parish S, Sleight P, Peto R (2004) Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363: 757-767.
17. Ramjee V, Jacobson TA (2011) Intensifying statin therapy to maximize cardiovascular risk reduction: is 50 the new 70? goals are getting old. Clin Lipidol 6: 131-136.
18. Oguz A, Temizhan A, Gulec S, Altuntas Y, Karsi{dotless}dag K, Akali{dotless}n AAK, Cali{dotless}k BT, Imeryuz N (2011) Dyslipidemia rates in age group 35-70 in Turkey. Obes Rev 7: 581-582.
19. Abaci{dotless} (2011) The current status of cardiovascular risk factors in Turkey. Arch Turk Soc Cardiol 39 (Suppl 4): 1-5.